ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
2
views
0
references
Top references
cited by
1
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
1,495
similar
All similar
Record
: found
Abstract
: not found
Article
: not found
THU0187: Safety profile of Upadacitinib up to 3 years of exposure in patients with Rheumatoid Arthritis.
Author(s):
SB Cohen
,
R Van Vollenhoven
,
JR Curtis
,
L CALABRESE
,
C Zerbini
,
Y Tanaka
Publication date:
2020
Journal:
Ann Rheum Dis.
Read this article at
ScienceOpen
Bookmark
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
UCL: UN SDG 03 Good Health and Well-Being
Data availability:
Comments
Comment on this article
Sign in to comment
Similar content
1,495
Upadacitinib for the treatment of rheumatoid arthritis.
Authors:
Lina Serhal
,
Christopher J. Edwards
Upadacitinib pharmacokinetics and exposure‐response analyses of efficacy and safety in psoriatic arthritis patients – Analyses of phase III clinical trials
Authors:
Elena Muensterman
,
Benjamin Engelhardt
,
Sathej Gopalakrishnan
…
Acne keloidalis nuchae in a patient with atopic dermatitis treated with Janus kinase inhibitor upadacitinib
Authors:
Nicolas Caudrelier
,
Hélène Veillette
See all similar
Cited by
1
Impact of Janus Kinase Inhibition on the Treatment of Axial Spondyloarthropathies
Authors:
Ariane Hammitzsch
,
Georg Lorenz
,
Philipp Moog
See all cited by